Company
Charleston Laboratories Inc, headquartered in Charleston, SC, is a privately funded specialty pharmaceutical company developing and commercializing opioid drugs with minimal or no opioid-induced nausea
and vomiting (OINV).
read more 
|
|
Charleston Laboratories Inc, will be attending the 2009 BIO International Convention, May 18-21 in Atlanta, GA. BIO International Convention is the largest global event for the biotechnology industry and attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on the major trends affecting the industry. Charleston Laboratories intends to enter into a strategic alliance for commercialization of CL-108 with partners motivated to introduce novel pain therapies.
|
 Recent News
May 18, 2009 - Charleston Laboratories, Inc. Completes Exploratory Bioequivalence Study of CL-108
April 28, 2009 - Charleston Laboratories, Inc. Appoints Kerry Segal Chief Business Development Advisor
Feburary 12, 2009 - Charleston Conducts Evaluation of an Opioid Symptoms Questionnaire
February 2, 2009 - Charleston Completes Preliminary Research on Nausea-Prone Questionnaire (NPQ)
January 12, 2009 - Charleston begins Bioequivalence Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CL-108
|
|
